Expression and prognostic values of ARID family members in breast cancer

被引：2

作者：

Zhang, Jinfeng ^{[1
]}

Hou, Siyu ^{[1
]}

You, Zilong ^{[1
]}

Li, Guozheng ^{[1
]}

Xu, Shouping ^{[1
]}

Li, Xianyong ^{[3
]}

Zhang, Xianyu ^{[1
]}

Lei, Bo ^{[1
]}

Pang, Da ^{[1
,2
]}

机构：

[1] Harbin Med Univ Canc Hosp, Dept Breast Surg, Harbin, Peoples R China

[2] Heilongjiang Acad Med Sci, Harbin, Peoples R China

[3] Harbin Med Univ, Dept Crit Care Med, Affiliated Hosp 1, Harbin, Peoples R China

来源：

AGING-US | 2021年 / 13卷 / 04期

基金：

中国国家自然科学基金;

关键词：

biomarkers; tumor; breast neoplasms; prognosis; HISTONE DEMETHYLASE; CONTRIBUTES; BINDING; RESISTANCE; SURVIVAL; JARID1B; GENES;

D O I：

暂无

中图分类号：

Q2 [细胞生物学];

学科分类号：

071009 ; 090102 ;

摘要：

The ARID family is a superfamily of 15 members containing a domain that interacts with AT-rich DNA elements. However, the expression and prognostic roles of each ARID in breast cancer are still elusive. We used the TCGA and Kaplan-Meier plotter databases to assess the expression and prognostic values of ARID mRNA levels in breast cancer respectively. In the present study, 6 members were significantly lower in tumor tissues than those in the normal tissues, while 6 members were significantly higher. Further assessment of ARID expression in breast cancer with different molecular subtypes, 3 members were significantly higher in noluminal molecular subtype than those in the luminal molecular subtype, and 6 members were significantly higher. In regard to prognostic values, high expression of ARID1A, ARID2, ARID3B, ARID4A, ARID5A, ARID5B, JARID1A were associated with favorable outcome, while ARID4B and JARID1B were correlated to a worse outcome. We further analyzed the prognostic value of ARID in different intrinsic subtypes and clinicopathological features of breast cancer. We found many meaningful ARID family biomarkers in breast cancer. The relevant results will expound the role of ARID in breast cancer and may further provide new insight to explore the ARID-targeting reagents for treating breast cancer patients.

引用

页码：5621 / 5637

页数：17

共 32 条

[1]

Akhavantabasi S, 2012, CELL STRUCT FUNCT, V37, P27

[2] HuR Reduces Radiation-Induced DNA Damage by Enhancing Expression of ARID1A [J].

Andrade, Daniel ;

Mehta, Meghna ;

Griffith, James ;

Oh, Sangphil ;

Corbin, Joshua ;

Babu, Anish ;

De, Supriyo ;

Chen, Allshine ;

Zhao, Yan D. ;

Husain, Sanam ;

Roy, Sudeshna ;

Xu, Liang ;

Aube, Jeffrey ;

Janknecht, Ralf ;

Gorospe, Myriam ;

Herman, Terence ;

Ramesh, Rajagopal ;

Munshi, Anupama .

CANCERS, 2019, 11 (12)

[3]

Aso T, 2015, ANTICANCER RES, V35, P6819

[4] Loss of ARID1A Activates ANXA1, which Serves as a Predictive Biomarker for Trastuzumab Resistance [J].

Berns, Katrien ;

Sonnenblick, Amir ;

Gennissen, Annemiek ;

Brohee, Sylvain ;

Hijmans, E. Marielle ;

Evers, Bastiaan ;

Fumagalli, Debora ;

Desmedt, Christine ;

Loibl, Sibylle ;

Denkert, Carsten ;

Neven, Patrick ;

Guo, Wei ;

Zhang, Fan ;

Knijnenburg, Theo A. ;

Bosse, Tjalling ;

van der Heijden, Michiel S. ;

Hindriksen, Sanne ;

Nijkamp, Wouter ;

Wessels, Lodewyk F. A. ;

Joensuu, Heikki ;

Mills, Gordon B. ;

Beijersbergen, Roderick L. ;

Sotiriou, Christos ;

Bernards, Rene .

CLINICAL CANCER RESEARCH, 2016, 22 (21) :5238-5248

[5] Effect of screening and adjuvant therapy on mortality from breast cancer [J].

Berry, DA ;

Cronin, KA ;

Plevritis, SK ;

Fryback, DG ;

Clarke, L ;

Zelen, M ;

Mandelblatt, JS ;

Yakovlev, AY ;

Habbema, JDF ;

Feuer, EJ .

NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (17) :1784-1792

[6] Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes [J].

Biankin, Andrew V. ;

Waddell, Nicola ;

Kassahn, Karin S. ;

Gingras, Marie-Claude ;

Muthuswamy, Lakshmi B. ;

Johns, Amber L. ;

Miller, David K. ;

Wilson, Peter J. ;

Patch, Ann-Marie ;

Wu, Jianmin ;

Chang, David K. ;

Cowley, Mark J. ;

Gardiner, Brooke B. ;

Song, Sarah ;

Harliwong, Ivon ;

Idrisoglu, Senel ;

Nourse, Craig ;

Nourbakhsh, Ehsan ;

Manning, Suzanne ;

Wani, Shivangi ;

Gongora, Milena ;

Pajic, Marina ;

Scarlett, Christopher J. ;

Gill, Anthony J. ;

Pinho, Andreia V. ;

Rooman, Ilse ;

Anderson, Matthew ;

Holmes, Oliver ;

Leonard, Conrad ;

Taylor, Darrin ;

Wood, Scott ;

Xu, Qinying ;

Nones, Katia ;

Fink, J. Lynn ;

Christ, Angelika ;

Bruxner, Tim ;

Cloonan, Nicole ;

Kolle, Gabriel ;

Newell, Felicity ;

Pinese, Mark ;

Mead, R. Scott ;

Humphris, Jeremy L. ;

Kaplan, Warren ;

Jones, Marc D. ;

Colvin, Emily K. ;

Nagrial, Adnan M. ;

Humphrey, Emily S. ;

Chou, Angela ;

Chin, Venessa T. ;

Chantrill, Lorraine A. .

NATURE, 2012, 491 (7424) :399-405

[7]

Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI [10.3322/caac.21492, 10.3322/caac.21609]

[8] Exome sequencing reveals frequent inactivating mutations in ARID1A, ARID1B, ARID2 and ARID4A in microsatellite unstable colorectal cancer [J].

Cajuso, Tatiana ;

Hanninen, Ulrika A. ;

Kondelin, Johanna ;

Gylfe, Alexandra E. ;

Tanskanen, Tomas ;

Katainen, Riku ;

Pitkanen, Esa ;

Ristolainen, Heikki ;

Kaasinen, Eevi ;

Taipale, Minna ;

Taipale, Jussi ;

Bohm, Jan ;

Renkonen-Sinisalo, Laura ;

Mecklin, Jukka-Pekka ;

Jarvinen, Heikki ;

Tuupanen, Sari ;

Kilpivaara, Outi ;

Vahteristo, Pia .

INTERNATIONAL JOURNAL OF CANCER, 2014, 135 (03) :611-623

[9] Recognition of an epitope of a breast cancer antigen by human antibody [J].

Cao, JN ;

Gao, TW ;

Giuliano, AE ;

Irie, RF .

BREAST CANCER RESEARCH AND TREATMENT, 1999, 53 (03) :279-290

[10] PLU-1/JARID1B/KDM5B is required for embryonic survival and contributes to cell proliferation in the mammary gland and in ER+ breast cancer cells [J].

Catchpole, Steven ;

Spencer-Dene, Bradley ;

Hall, Debbie ;

Santangelo, Samantha ;

Rosewell, Ian ;

Guenatri, Mounia ;

Beatson, Richard ;

Scibetta, Angelo G. ;

Burchell, Joy M. ;

Taylor-Papadimitriou, Joyce .

INTERNATIONAL JOURNAL OF ONCOLOGY, 2011, 38 (05) :1267-1277

← 1 2 3 4 →